TSX Penny Stocks To Watch In January 2025

In This Article:

The Canadian market has been navigating the implications of new U.S. policies, with a particular focus on energy and tariffs, while the TSX index has shown resilience since Inauguration Day. Amid these broader economic shifts, penny stocks remain an intriguing segment for investors seeking potential growth opportunities. Although often associated with smaller or newer companies, these stocks can offer significant value when backed by strong financials and strategic positioning in their respective industries.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Alvopetro Energy (TSXV:ALV)

CA$4.95

CA$189.37M

★★★★★★

Silvercorp Metals (TSX:SVM)

CA$4.46

CA$933.34M

★★★★★★

Mandalay Resources (TSX:MND)

CA$4.57

CA$406.63M

★★★★★★

Foraco International (TSX:FAR)

CA$2.21

CA$222.46M

★★★★★☆

PetroTal (TSX:TAL)

CA$0.67

CA$619.93M

★★★★★★

Pulse Seismic (TSX:PSD)

CA$2.29

CA$123.03M

★★★★★★

Findev (TSXV:FDI)

CA$0.48

CA$14.18M

★★★★★★

NamSys (TSXV:CTZ)

CA$1.00

CA$26.86M

★★★★★★

East West Petroleum (TSXV:EW)

CA$0.04

CA$3.62M

★★★★★★

Tornado Infrastructure Equipment (TSXV:TGH)

CA$1.02

CA$140.31M

★★★★★☆

Click here to see the full list of 936 stocks from our TSX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Telescope Innovations

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Telescope Innovations Corp. is a chemical technology company focused on developing manufacturing processes and tools for the pharmaceutical and chemical industries in the United States and Canada, with a market cap of CA$22.55 million.

Operations: No revenue segments have been reported.

Market Cap: CA$22.55M

Telescope Innovations Corp., a pre-revenue chemical technology company, has demonstrated promising advancements with its ReCRFTTM technology, successfully producing high-purity lithium carbonate from diverse North American brines. Despite being unprofitable and having a negative return on equity, the company is debt-free and maintains a cash runway exceeding three years due to positive free cash flow growth. However, recent auditor concerns about its ability to continue as a going concern highlight financial risks. While trading below estimated fair value suggests potential upside, short-term liabilities exceed assets, posing challenges for financial stability.

CNSX:TELI Debt to Equity History and Analysis as at Jan 2025
CNSX:TELI Debt to Equity History and Analysis as at Jan 2025

Bri-Chem

Simply Wall St Financial Health Rating: ★★★★★☆